Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
Ontology highlight
ABSTRACT: Synthetic cannabinoid intake is an ongoing health issue worldwide, with new compounds continually emerging, making drug testing complex. Parent synthetic cannabinoids are rarely detected in urine, the most common matrix employed in workplace drug testing. Optimal identification of synthetic cannabinoid markers in authentic urine specimens and correlation of metabolite concentrations and toxicities would improve synthetic cannabinoid result interpretation. We screened 20 017 randomly collected US military urine specimens between July 2011 and June 2012 with a synthetic cannabinoid immunoassay yielding 1432 presumptive positive specimens. We analyzed all presumptive positive and 1069 negative specimens with our qualitative synthetic cannabinoid liquid chromatography-tandem mass spectrometry
SUBMITTER: Castaneto MS
PROVIDER: S-EPMC4363290 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA